Ironwood Pharmaceuticals | IRWD - Fremdkapital





Fremdkapital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 48.25M 609K 2025-12
Almirall EUR 324.81M 61.32M 2025-12
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Ardelyx USD 202.83M 696K 2025-12
Astellas Pharma JPY 320B 0 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Coherus Biosciences USD 51.08M 496K 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Exact Sciences USD 2.33B 9.34M 2025-09
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Incyte USD 30.2M 5.17M 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD -0.93 0.67 2024-12
Lexicon Pharmaceuticals USD 49.41M 7.1M 2025-12
MacroGenics USD 70M 256K 2025-12
Moderna USD 610M 584M 2025-12
Myriad Genetics USD 119.9M 400K 2025-12
Pacira USD 372.19M 4.53M 2025-12
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Takeda JPY 4.27T 81.29B 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12